| Proton radiotherapy for orbital rhabdomyosarcoma: clinical outcome and a dosimetric comparison with photons T Yock, R Schneider, A Friedmann, J Adams, B Fullerton, N Tarbell International Journal of Radiation Oncology* Biology* Physics 63 (4), 1161-1168, 2005 | 204 | 2005 |
| Do basic laboratory tests or clinical observations predict bleeding in thrombocytopenic oncology patients? A reevaluation of prophylatic, platelet transfusions AM Friedmann, H Sengul, H Lehmann, C Schwartz, S Goodman Transfusion medicine reviews 16 (1), 34-45, 2002 | 184 | 2002 |
| Evaluation and management of lymphadenopathy in children AM Friedmann Pediatrics in Review 29 (2), 53-60, 2008 | 150 | 2008 |
| Outcome in children with standard-risk B-cell acute lymphoblastic leukemia: results of Children’s Oncology Group Trial AALL0331 KW Maloney, M Devidas, C Wang, LA Mattano, AM Friedmann, P Buckley, ... Journal of Clinical Oncology 38 (6), 602-612, 2020 | 146 | 2020 |
| Preliminary results of a phase II trial of proton radiotherapy for pediatric rhabdomyosarcoma MM Ladra, JD Szymonifka, A Mahajan, AM Friedmann, B Yong Yeap, ... Journal of Clinical Oncology 32 (33), 3762-3770, 2014 | 143 | 2014 |
| Proton radiotherapy for parameningeal rhabdomyosarcoma: clinical outcomes and late effects SK Childs, KR Kozak, AM Friedmann, BY Yeap, J Adams, SM MacDonald, ... International Journal of Radiation Oncology* Biology* Physics 82 (2), 635-642, 2012 | 125 | 2012 |
| Association between radiotherapy vs no radiotherapy based on early response to VAMP chemotherapy and survival among children with favorable-risk Hodgkin lymphoma ML Metzger, HJ Weinstein, MM Hudson, AL Billett, EC Larsen, ... Jama 307 (24), 2609-2616, 2012 | 119 | 2012 |
| The role of prognostic features in the treatment of childhood acute lymphoblastic leukemia AM Friedmann, HJ Weinstein The Oncologist 5 (4), 321-328, 2000 | 115 | 2000 |
| Risk-adapted, combined-modality therapy with VAMP/COP and response-based, involved-field radiation for unfavorable pediatric Hodgkin's disease MM Hudson, M Krasin, MP Link, SS Donaldson, C Billups, TE Merchant, ... Journal of Clinical Oncology 22 (22), 4541-4550, 2004 | 111 | 2004 |
| A dosimetric comparison of proton and intensity modulated radiation therapy in pediatric rhabdomyosarcoma patients enrolled on a prospective phase II proton study MM Ladra, SK Edgington, A Mahajan, D Grosshans, J Szymonifka, ... Radiotherapy and Oncology 113 (1), 77-83, 2014 | 109 | 2014 |
| Proton radiotherapy for pediatric bladder/prostate rhabdomyosarcoma: clinical outcomes and dosimetry compared to intensity-modulated radiation therapy SE Cotter, DA Herrup, A Friedmann, SM Macdonald, RV Pieretti, ... International Journal of Radiation Oncology* Biology* Physics 81 (5), 1367-1373, 2011 | 108 | 2011 |
| Treatment of unfavorable childhood Hodgkin’s disease with VEPA and low-dose, involved-field radiation AM Friedmann, MM Hudson, HJ Weinstein, SS Donaldson, L Kun, ... Journal of Clinical oncology 20 (14), 3088-3094, 2002 | 94 | 2002 |
| Whole-body MR imaging for staging of malignant tumors in pediatric patients: results of the American College of Radiology Imaging Network 6660 Trial MJ Siegel, S Acharyya, FA Hoffer, JB Wyly, AM Friedmann, BS Snyder, ... Radiology 266 (2), 599-609, 2013 | 76 | 2013 |
| Proton radiotherapy for high-risk pediatric neuroblastoma: early outcomes and dose comparison JA Hattangadi, B Rombi, TI Yock, G Broussard, AM Friedmann, M Huang, ... International Journal of Radiation Oncology* Biology* Physics 83 (3), 1015-1022, 2012 | 66 | 2012 |
| Induction of fetal hemoglobin synthesis in children with sickle cell anemia on low-dose oral sodium phenylbutyrate therapy LMS Resar, JB Segal, LK Fitzpatric, A Friedmann, SW Brusilow, GJ Dover Journal of pediatric hematology/oncology 24 (9), 737-741, 2002 | 48 | 2002 |
| Proton therapy for pediatric and adolescent esthesioneuroblastoma JT Lucas Jr, MM Ladra, SM MacDonald, PM Busse, AM Friedmann, ... Pediatric blood & cancer 62 (9), 1523-1528, 2015 | 47 | 2015 |
| Excellent outcome for pediatric patients with high-risk Hodgkin lymphoma treated with brentuximab vedotin and risk-adapted residual node radiation ML Metzger, MP Link, AL Billett, J Flerlage, JT Lucas Jr, BN Mandrell, ... Journal of Clinical Oncology 39 (20), 2276-2283, 2021 | 44 | 2021 |
| Relapse after treatment of pediatric Hodgkin lymphoma: outcome and role of surveillance after end of therapy AM Friedmann, JA Wolfson, MM Hudson, HJ Weinstein, MP Link, A Billett, ... Pediatric blood & cancer 60 (9), 1458-1463, 2013 | 36 | 2013 |
| Contrasting features of childhood and adolescent melanomas DW Bartenstein, CM Kelleher, AM Friedmann, LM Duncan, H Tsao, ... Pediatric dermatology 35 (3), 354-360, 2018 | 35 | 2018 |
| Histiocytic and dendritic cell sarcomas of hematopoietic origin share targetable genomic alterations distinct from follicular dendritic cell sarcoma LR Massoth, YP Hung, JA Ferry, RP Hasserjian, V Nardi, GP Nielsen, ... The Oncologist 26 (7), e1263-e1272, 2021 | 34 | 2021 |
